OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexins cause epileptic activity
Haydar Ali Erken, Gülten Erken, Osman Genç, et al.
Peptides (2012) Vol. 37, Iss. 1, pp. 161-164
Closed Access | Times Cited: 25

Showing 25 citing articles:

Orexin receptor antagonists in the pathophysiology and treatment of sleep disorders and epilepsy
Mohammad Sheibani, Maryam Shayan, Mina Khalilzadeh, et al.
Neuropeptides (2023) Vol. 99, pp. 102335-102335
Closed Access | Times Cited: 18

Transient targeting of hypothalamic orexin neurons alleviates seizures in a mouse model of epilepsy
Han‐Tao Li, Paulius Viskaitis, Edward F. Bracey, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6

Orexin-A-induced ERK1/2 activation reverses impaired spatial learning and memory in pentylenetetrazol-kindled rats via OX1R-mediated hippocampal neurogenesis
Xuan Zhao, Rui xue Zhang, Shi Tang, et al.
Peptides (2013) Vol. 54, pp. 140-147
Closed Access | Times Cited: 63

Mechanistic insights into the interaction between epilepsy and sleep
Laurent Sheybani, Birgit Frauscher, Christophe Bernard, et al.
Nature Reviews Neurology (2025)
Closed Access

Role of the orexin system in the bidirectional relation between sleep and epilepsy: New chances for patients with epilepsy by the antagonism to orexin receptors?
Chiara Berteotti, Carmen Calvello, Claudio Liguori
Epilepsia (2023) Vol. 64, Iss. 8, pp. 1991-2005
Open Access | Times Cited: 12

Level of S100B protein, neuron specific enolase, orexin A, adiponectin and insulin-like growth factor in serum of pediatric patients suffering from sleep disorders with or without epilepsy
Marek Kaciński, Bogusława Budziszewska, Władysław Lasoń, et al.
Pharmacological Reports (2012) Vol. 64, Iss. 6, pp. 1427-1433
Closed Access | Times Cited: 42

Hippocampal orexin receptors inactivation reduces PTZ induced seizures of male rats
Elham Goudarzi, Mahmoud Elahdadi Salmani, Taghi Lashkarbolouki, et al.
Pharmacology Biochemistry and Behavior (2015) Vol. 130, pp. 77-83
Closed Access | Times Cited: 37

SB-334867, an orexin receptor 1 antagonist, decreased seizure and anxiety in pentylenetetrazol-kindled rats
Elham Kordi Jaz, Ali Moghimi, Masoud Fereidoni, et al.
Fundamental and Clinical Pharmacology (2016) Vol. 31, Iss. 2, pp. 201-207
Closed Access | Times Cited: 33

Progressive cardiorespiratory dysfunction in Kv1.1 knockout mice may provide temporal biomarkers of pending sudden unexpected death in epilepsy (SUDEP): The contribution of orexin
Shruthi H. Iyer, Ankita Aggarwal, Ted J. Warren, et al.
Epilepsia (2020) Vol. 61, Iss. 3, pp. 572-588
Closed Access | Times Cited: 25

Orexins role in neurodegenerative diseases: From pathogenesis to treatment
Derbew Fikadu Berhe, Abadi Kahsu Gebre, Brhane Teklebrhan Assefa
Pharmacology Biochemistry and Behavior (2020) Vol. 194, pp. 172929-172929
Closed Access | Times Cited: 21

Des-acyl ghrelin attenuates pilocarpine-induced limbic seizures via the ghrelin receptor and not the orexin pathway
Jeanelle Portelli, Jessica Coppens, Thomas Demuyser, et al.
Neuropeptides (2015) Vol. 51, pp. 1-7
Closed Access | Times Cited: 20

SB 334867, a selective orexin receptor type 1 antagonist, elevates seizure threshold in mice
Katarzyna Socała, Agnieszka Szuster−Ciesielska, Piotr Właź
Life Sciences (2016) Vol. 150, pp. 81-88
Closed Access | Times Cited: 16

Lateral hypothalamus orexinergic system modulates the stress effect on pentylenetetrazol induced seizures through corticotropin releasing hormone receptor type 1
Maryam Mokhtarpour, Mahmoud Elahdadi Salmani, Taghi Lashkarbolouki, et al.
Neuropharmacology (2016) Vol. 110, pp. 15-24
Closed Access | Times Cited: 15

The role of Orexin-A levels in epileptic seizure
Halil İbrahim ÇIKRIKLAR, Dilcan Kotan, Murat Yücel, et al.
Neuroscience Letters (2020) Vol. 734, pp. 135097-135097
Closed Access | Times Cited: 9

Targeting the orexinergic system: Mainly but not only for sleep-wakefulness therapies
Abdelaziz Ghanemi, Xintian Hu
Alexandria Journal of Medicine (2014) Vol. 51, Iss. 4, pp. 279-286
Open Access | Times Cited: 8

Suvorexant, a Dual Orexin Receptor Antagonist, Protected Seizure through Interaction with GABAA and Glutamate Receptors.
Bibi Marjan Razavi, Omid Farivar, Leila Etemad, et al.
PubMed (2020) Vol. 19, Iss. 2, pp. 383-390
Closed Access | Times Cited: 7

Relation between orexin A and epileptic seizures
Gokce Ayhan Arslan, Serap Saygı, Ebru Bodur, et al.
Epilepsy Research (2022) Vol. 184, pp. 106972-106972
Closed Access | Times Cited: 4

Proconvulsant Effect of NUCB2/Nesfatin-1
Haydar Ali Erken, Emine Rabia Koç, Gülten Erken, et al.
International Journal of Peptide Research and Therapeutics (2014) Vol. 21, Iss. 1, pp. 29-38
Closed Access | Times Cited: 3

Changes in sensorimotor cortex oscillatory activity by orexin‐A in the ventrolateral preoptic area of the hypothalamus reflect increased muscle tone
Vijayakumar Mavanji, Jennifer A. Teske, Catherine M. Kotz, et al.
Journal of Neuroscience Research (2023) Vol. 101, Iss. 8, pp. 1305-1323
Open Access | Times Cited: 1

Transient targeting of hypothalamic orexin neurons alleviates seizures in a mouse model of epilepsy
Han‐Tao Li, Paulius Viskaitis, Edward F. Bracey, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

Compensatory actions of orexinergic neurons in the lateral hypothalamus during metabolic or cortical challenges may enable the coupling of metabolic dysfunction and cortical dysfunction
Sang‐Woo Kim, Kyoung Joo Cho, Byung In Lee
Medical Hypotheses (2013) Vol. 80, Iss. 5, pp. 520-526
Closed Access | Times Cited: 1

Dopaminergic System: Selected Advances and Emerging Potential Therapeutic Targets
Abdelaziz Ghanemi
International Journal of Public Health Science (IJPHS) (2013) Vol. 2, Iss. 2
Closed Access

Glymphatic system and aquaporin‑4 in epilepsy
Dorota Nowicka
Acta Neurobiologiae Experimentalis (2023), pp. 117-128
Open Access

Pharmacology of Orexin/Hypocretin Receptors
Jyrki P. Kukkonen
Elsevier eBooks (2019), pp. 31-68
Closed Access

Page 1

Scroll to top